ArticleScientific reports2026
First-principles investigation of aspirin, paracetamol, and ibuprofen adsorption on triquinoxalinylene and benzoquinone-based covalent organic framework.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical contaminants such as aspirin (ASP), paracetamol (PAR), and ibuprofen (IBU) present increasing risks to environmental and human health, necessitating efficient detection and removal strategies. In this study, we performed a comprehensive first-principles investigation of their adsorption on a triquinoxalinylene and benzoquinone-based covalent organic framework (TQBQ-COF). The geometries were optimized and the adsorption complexes were characterized using density functional theory. The results reveal that all three drug molecules are effectively accommodated within the electron-rich central cavity of the COF, forming stable host-guest assemblies through van der Waals interactions while preserving the structural integrity of the framework. Frontier molecular orbital and global reactivity analyses indicate that drug adsorption, particularly for IBU, significantly reduces the HOMO-LUMO gap and chemical hardness, enhancing electronic sensitivity, reactivity, and charge-transfer capability. Electron density difference and non-covalent interaction analyses confirm directional electron flow from the drugs to the COF and identify stabilizing interactions governing adsorption. Simulated UV-Vis spectra show pronounced red-shifts upon drug adsorption, with the IBU@TQBQ-COF complex exhibiting the largest effect. Thermodynamic analyses further confirm spontaneous, exothermic adsorption dominated by enthalpy contributions. Collectively, these findings highlight TQBQ-COF as a highly sensitive and robust platform for drug detection and removal in aqueous and biologically relevant environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.